Your search found 1111 Results
Southern Medical Journal. 2016 Oct; 109(10):621-627.Add to my documents.
Effect of oral versus intrauterine progestins on weight in women undergoing fertility preserving therapy for complex atypical hyperplasia or endometrial cancer.
Gynecologic Oncology. 2016 Feb; 140(2):234-8.Add to my documents.
Journal of Women's Health. 2015 Nov; 24(11):899-906.Add to my documents.
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Cochrane Database of Systematic Reviews. 2015; 12:CD007245.Add to my documents.
Open Access Journal of Contraception. 2011 Oct 18; 2:127-136.Add to my documents.
Progesterone-based intrauterine device use is associated with a thinner apical layer of the human ectocervical epithelium and a lower ZO-1 mRNA expression.
Biology of Reproduction. 2015 Mar; 92(3):68.Add to my documents.
Lancet. Oncology. 2015 Nov; 16(15):e527.Add to my documents.
Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies.
Lancet. Oncology. 2015 Aug 4;Add to my documents.
Improving treatment for obese women with early stage cancer of the uterus: rationale and design of the levonorgestrel intrauterine device +/- metformin +/- weight loss in endometrial cancer (feMME) trial.
Contemporary Clinical Trials. 2014 Sep; 39(1):14-21.Add to my documents.
Taiwanese Journal of Obstetrics and Gynecology. 2014 Jun; 53(2):267-9.Add to my documents.
Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium.
International Journal of Cancer. 2015 Mar 1; 136(5):E410-22.Add to my documents.
Risk-benefit assessment of the combined oral contraceptive pill in women with a family history of female cancer.
Expert Opinion On Drug Safety. 2014 Aug 22; 1-8.Add to my documents.
Australian and New Zealand Journal of Obstetrics & Gynaecology. 2013 Dec; 53(6):566-70.Add to my documents.
Obstetrics and Gynecology. 2014 May; 123 Suppl 1:183S.Add to my documents.
Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma.
American Journal of Obstetrics and Gynecology. 2014 Mar; 210(3):255.e1-4.Add to my documents.
Steroids. 2013 Aug; 78(8):782-5.Add to my documents.
Combined medroxyprogesterone acetate/levonorgestrel-intrauterine system treatment in young women with early-stage endometrial cancer.
American Journal of Obstetrics and Gynecology. 2013 Oct; 209(4):358.e1-4.Add to my documents.
Cancer Epidemiology, Biomarkers and Prevention. 2013 Dec 10;Add to my documents.
Cochrane Database of Systematic Reviews. 2013; 6:CD009458.Add to my documents.
Oral Contraceptive Use and Risk of Breast, Cervical, Colorectal, and Endometrial Cancers: A Systematic Review.
Cancer Epidemiology, Biomarkers and Prevention. 2013 Sep 6;Add to my documents.
Prospective, Multi-center Randomized Intermediate Biomarker Study of Oral Contraceptive vs. Depo-Provera for Prevention of Endometrial Cancer in Women with Lynch Syndrome.
Cancer Prevention Research. 2013 May 2;Add to my documents.
Cancer. 2013 Apr 1; 119(7):1393-401.Add to my documents.
Middle East Fertility Society Journal. 2011 Dec; 16(4):248-253.Add to my documents.
Contraception. 2012 Dec; 86(6):772.Add to my documents.
Incidence and factors associated with synchronous ovarian and endometrial cancer: a population-based case-control study.
Gynecologic Oncology. 2012 Apr; 125(1):109-13.Add to my documents.